Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations
Gene Expression Regulation, Leukemic
Intracellular Signaling Peptides and Proteins
Leukemia, Lymphocytic, Chronic, B-Cell
Phospholipase C gamma
Receptors, Antigen, B-Cell
Lymphoma Research Foundation, Lymphoma Research Fund (Andrew D Zelenetz), and National Institutes of Health/National Cancer Institute.